04/26/2024
3:12 PM | Nektar Therapeutics (Filer)
| Form ARS | |
04/17/2024
4:03 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
3:38 PM | Nektar Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/15/2024
3:18 PM | Nektar Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
03/14/2024
3:30 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
4:11 PM | Nektar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/04/2024
7:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:16 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:17 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:19 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
2:50 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:51 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:50 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
3:25 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:18 AM | Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2023
3:55 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
7:58 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:00 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:02 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:36 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
7:07 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:06 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:07 PM | Brainard Diana (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:08 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:09 PM | Curet Myriam (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:11 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:06 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
4:16 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
7:06 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
7:07 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
7:08 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:30 PM | Nektar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
08/11/2023
8:31 PM | Nektar Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2023
5:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
1:09 PM | Invesco Ltd. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
07/10/2023
9:41 AM | Nektar Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/07/2023
12:28 PM | Nektar Therapeutics (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SC 13G/A | |
07/03/2023
3:02 PM | CITADEL ADVISORS LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
06/22/2023
7:12 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
5:26 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:15 PM | Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
7:28 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
7:29 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
7:27 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
10:52 AM | BlackRock Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
04/27/2023
7:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
